A Phase I/II Open-label Clinical Trial to Evaluate the Pharmacokinetics of Alectinib With Sequential Dose Escalation in Patients Diagnosed With ALK-rearranged Advanced Non-small Cell Lung Cancer.
NCT05713006 · RECRUITING · Phase 2
ReadTheTrial indexes 1 studies for Non Small Cell Lung Cancer Stage Iiib. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Non Small Cell Lung Cancer Stage Iiib.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
There are 1 clinical trials listed for Non Small Cell Lung Cancer Stage Iiib. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Non Small Cell Lung Cancer Stage Iiib trials are distributed across: Phase 2 (1).